Kathie Jordan, Ph.D.

Previously led the Coulter-Drexel Translational Research Partnership, an endowed non-dilutive fund with a portfolio of 70+ technologies, ranging from small molecule therapeutics to medical devices and diagnostics. Kathie turned the program from a 3x to 33x leverage of funds invested relative to follow-on funding.